AIM - AIM ImmunoTech Inc.

QQQ $ 482.88 $ 2.24 (0.47 %)

DIA $ 408.91 $ 0.43 (0.11 %)

SPY $ 560.81 $ 1.92 (0.34 %)

TLT $ 98.72 $ 0.06 (0.06 %)

GLD $ 232.16 $ -0.31 (-0.13 %)

Previous Close

$ 0.3939

Open

$ 0.38

Bid

$ 0.32 x 100

Ask

-- x --

Day's Range

$ 0.38 - $ 0.39

52 Week Range

$ 0.25 - $ 0.70

Volume

449,887

Average Volume

Market Cap

20.81M

Beta (5Y Monthly)

$ -0.21

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-14-2024	06-30-2024	10-Q
2	05-15-2024	03-31-2024	10-Q
3	03-30-2024	12-31-2023	10-K
4	11-14-2023	09-30-2023	10-Q
5	08-14-2023	06-30-2023	10-Q
6	05-15-2023	03-31-2023	10-Q
7	03-31-2023	12-31-2022	10-K
8	11-14-2022	09-30-2022	10-Q
9	08-15-2022	06-30-2022	10-Q
10	05-13-2022	03-31-2022	10-Q
11	03-31-2022	12-31-2021	10-K
12	11-15-2021	09-30-2021	10-Q
13	08-16-2021	06-30-2021	10-Q
14	05-17-2021	03-31-2021	10-Q
15	03-31-2021	12-31-2020	10-K
16	11-12-2020	09-30-2020	10-Q
17	08-14-2020	06-30-2020	10-Q
18	05-14-2020	03-31-2020	10-Q
19	03-30-2020	12-31-2019	10-K
20	11-14-2019	09-30-2019	10-Q
21	08-14-2019	06-30-2019	10-Q
22	05-15-2019	03-31-2019	10-Q
23	04-01-2019	12-31-2018	10-K
24	11-14-2018	09-30-2018	10-Q
25	08-14-2018	06-30-2018	10-Q
26	05-15-2018	03-31-2018	10-Q
27	03-30-2018	12-31-2017	10-K
28	11-14-2017	09-30-2017	10-Q
29	08-14-2017	06-30-2017	10-Q
30	05-15-2017	03-31-2017	10-Q
31	03-31-2017	12-31-2016	10-K
32	11-14-2016	09-30-2016	10-Q
33	08-15-2016	06-30-2016	10-Q
34	05-16-2016	03-31-2016	10-Q
35	03-29-2016	12-31-2015	10-K
36	11-16-2015	09-30-2015	10-Q
37	08-12-2015	06-30-2015	10-Q
38	05-12-2015	03-31-2015	10-Q
39	03-19-2015	12-31-2014	10-K
40	11-07-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

AIM ImmunoTech Announces Print Publication...
08/20/2024 12:32:29

AIM ImmunoTech Inc. (NYSE:AIM) ("AIM") today announced the official print publication of the data analysis from a long-...

AIM ImmunoTech Q2 2024 GAAP EPS $(0.03) Be...
08/16/2024 11:25:54

AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.12) b...

AIM ImmunoTech Announces New Pre-Clinical ...
07/24/2024 12:50:35

ImmunoTech Announces Pricing Of 5,640,958 ...
05/31/2024 12:33:54

AIM ImmunoTech Q1 2024 GAAP EPS $(0.12), I...
05/16/2024 10:54:49

AIM ImmunoTech Completes cGMP Manufacturin...
05/06/2024 12:38:39

AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today announced the successfully completion of cGMP man...

AIM ImmunoTech Complete Safety Evaluation ...
04/29/2024 12:57:53

AIM ImmunoTech Announces Top-Line, Protoco...
04/10/2024 12:22:06

AIM ImmunoTech Q4 EPS $(0.26) Misses $(0.1...
04/03/2024 02:58:19

AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.15)...

AIM ImmunoTech Reported Cash, Cash Equival...
04/02/2024 11:34:34

Earnings Scheduled For April 2, 2024
04/02/2024 10:25:53

Companies Reporting Before The Bell • Ocugen (NASDAQ:OCGN) is estimated to report earnings for its fourth quarter.

Preview: AIM ImmunoTech's Earnings
04/01/2024 18:05:38

Earnings Scheduled For March 26, 2024
03/26/2024 08:47:27

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on reve...

AIM ImmunoTech Announces Publication Of Fi...
03/25/2024 13:10:22

aim-immunotech-and-3-other-stocks-under-3-insiders-are-buying

AIM ImmunoTech And 3 Other Stocks Under $3...
03/25/2024 10:33:28

The Dow Jones index closed lower by over 300 points on Friday. When insiders purchase or sell shares, it indicates their confid...

AIM ImmunoTech Launches CEO Corner Platform
03/07/2024 13:46:06

CEO Corner segments to provide added perspective to press releases, corporate developments and pipeline progress Provides inter...

AIM ImmunoTech Announces First Subject Dos...
02/14/2024 13:56:38

The DURIPANC Study is an investigator-initiated, exploratory, open-label, single-center study with the full name "Combining...

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
02/12/2024 21:30:59

AIM ImmunoTech Reports Topline Results Fro...
02/08/2024 13:52:24

Efficacy results offer preliminary evidence that Ampligen may reduce fatigue in subjects with Post-COVID conditions Safety resu...

AIM ImmunoTech Receives Erasmus Medical Ce...
01/24/2024 14:12:57